EYE - National Vision Holdings Kompaniya qiymatining foyda o‘sish sur’atiga nisbati

America's Best Contacts & Eyeglasses (EYE) tovar belgisi

National Vision Holdings (EYE) kompaniyasining salohiyati yirik tarmoqlar bilan hamkorlikka va ko'rish diagnostikasiga bo'lgan barqaror talabga asoslangan bo'lib, bu P/E o'sish salohiyati ko'rsatkichi bilan tasdiqlanadi. Shu bilan birga, 0.81 qiymati joriy dinamikani aks ettiradi. Xatarlar iste'mol xarajatlarining kamayishi va onlayn platformalarning narxlariga bo'lgan bosimi bilan bog'liq, ammo o'zining optika laboratoriyalarining yuqori samaradorligi mahsulot ishlab chiqarishning uzluksizligini kafolatlaydi.

EYE (National Vision) PEG multiplikatori tarixi 04.07.2022dan 16.11.2026gacha

National Vision Holdings, Inc. (EYE) kompaniyasining tahliliy kesimlari

Kompaniyaning fundamental tahlili:EYE - America's Best Contacts & Eyeglasses
National Vision brendining mahsuloti

Portfel menejerining nuqtai nazaridan, P/E va o'sish sur'atlarining ushbu taqqoslovi joriy foyda ko'paytirgichini kutilayotgan o'sish sur'atiga bo'lish orqali qadrsizlangan aktivlarni aniqlaydi. National Vision Holdings (EYE) uchun ushbu ko'rsatkich juda muhimdir, chunki u AQSh budjetli optika segmentiga kengayish va shaxsiy brendlarni rivojlantirish qanchalik samarali tarzda aksiyadorlik bozoridagi qiymatga aylanayotganini ko'rsatadi.

National Vision Holdings raqobatchilari

HCA Holdings - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Tenet - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati FMS (Fresenius Medical Care)|SOLV: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Encompass Health Corp|Universal Health Services (UHS) - Narxning foydaga va o‘sish sur’atiga nisbati|DaVita Inc. (DVA) - PEG multiplikatori|RDNT (RadNet Management) - PEG multiplikatori|Option Care Health, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Surgery Partners (SGRY)|PINC - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - O‘sish sur’atiga tuzatilgan narx-foyda|SEM: Narx-foyda va o‘sish multiplikatori|ASTH - PEG multiplikatori|MD: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati USPH (US Physical Therapy)|Narxning foydaga va o‘sish sur’atiga nisbati The Pennant Group, Inc.|ORGO - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori NUTX|PEG multiplikatori Auna (AUNA)|PEG multiplikatori SBC (sbc-holdings.com)|EOLS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Community Health Systems Inc - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda The Beauty Health Company|MediWound Ltd (MDWD) - Narxning foydaga va o‘sish sur’atiga nisbati|BTMD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati The Joint|Narx-foyda va o‘sish multiplikatori DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori Gain Therapeutics (GANX)|PEG multiplikatori EUDA (EUDA Health)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BMGL|CollPlant Ltd - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Narxning foydaga va o‘sish sur’atiga nisbati|ASHS - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati MEDIROM Healthcare Group|PEG multiplikatori avalon-globocare.com|PEG multiplikatori DHAI|XAGE (Carmell Therapeutics Corporation) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NewGenIvf Corp NIVF|ATIP (atipt.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|CareMax, Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KDLY (Kindly MD, Inc.)|MODV: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NVOS|Narxning foydaga va o‘sish sur’atiga nisbati SunLink Health Systems, Inc.|PEG multiplikatori IMAC Holdings, Inc.